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The yeast pheromone receptor, Ste2p, is a G protein coupled receptor that initiates cellular responses to α-mating pheromone, a 13 residue
peptide that carries a net positive charge at physiological pH. We have examined the role of extracellular charged groups on the receptor in
response to the pheromone. Substitutions of Asn or Ala for one extracellular residue, Asp275, affected both pheromone binding and signaling,
suggesting that this position interacts directly with ligand. The other seven extracellular acidic residues could be individually replaced by polar
residues with no detectable effects on receptor function. However, substitution of Ala for each of these seven residues resulted in impairment of
signaling without affecting pheromone binding, implying that the polar nature of these residues promotes receptor activation. In contrast,
substitution of Ala for each of the six positively charged residues at the extracellular surface of Ste2p did not affect signaling.
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G protein coupled receptors (GPCRs) comprise a large
superfamily of cellular receptors that mediate responses to a
wide variety of stimuli [1–3]. GPCRs are activated by binding
of a diverse set of ligands, including proteins, peptides, ions,
biogenic amines, lipids, large glycoprotein hormones, and
odorant molecules. Binding of ligands at the extracellular
surfaces of GPCRs results in transmission of a signal to the
cytoplasmic surface that induces exchange of GTP for GDP
bound to cytoplasmic heterotrimeric G proteins [4].
Ligands bind to receptors in diverse ways, eliciting a variety
of signaling responses [5,6]. The molecular mechanismsAbbreviations: GPCR, G protein coupled receptor; [Orn7(NBD), Nle12]
α-factor, (Ornithine7 (7-nitrobenz-2-oxa-1,3-diazol-4-yl), norleucine12 α-factor);
[Orn7(NBD), E10, Nle12], α-factor; (Ornithine7 (7-nitrobenz-2-oxa-1,3-diazol-4-
yl), Glu10, norleucine12α-factor); [K7(NBD),Nle12]α-factor, (Lys7 (7-nitrobenz-2-
oxa-1,3-diazol-4-yl), norleucine12 α-factor); HA epitope, hemagglutinin 12CA5
epitope
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doi:10.1016/j.bbamcr.2007.02.002underlying receptor activation by certain ligands and antag-
onistic effects of other ligands remain poorly understood.
Detailed characterization of the ligand-binding sites on GPCRs
and understanding ligand–receptor interactions that mediate
activation can provide critical constraints for the design of
specific receptor agonists and antagonists [7]. However, for
many classes of GPCRs, such as receptors for peptide hormones,
the identities of groups that mediate the interactions with ligands
have not yet been established.
To date, the only high-resolution crystal structure of a
complete GPCR is that of the unactivated state of bovine
rhodopsin [8], a receptor that is activated by light absorption,
rather than ligand binding. Structures of the large extracellular
ligand-binding domains of human follicle stimulating hormone
receptor in complex with ligand [9] and of the metabotropic
glutamate receptor [10] are also available. However, the
mechanisms by which signaling initiated by these extracellular
domains is transmitted to the transmembrane and intracellular
regions of this receptor remain obscure.
In the absence of detailed structural information, site-
directed mutagenesis in combination with biochemical analysis
has been useful in identifying specific interactions between
chemical groups on GPCRs and chemical groups on ligands.
Binding of ligands to many mammalian GPCRs involves ionic
Table 1
Plasmids and yeast strains
STE2 allele Mutagenic oligonucleotide Plasmid Yeast strain
(ste2-Δ Host strain A232)
STE2+ – pMD240 A448
ste2-Δ – pMD228 A454
D3A ON 460 pMD963 A2360
D14A ON 461 pMD964 A2361
D39A ON 462 pMD965 A2362
E40A ON 463 pMD966 A2363
D124A ON 464 pMD967 A2364
D195A ON 465 pMD968 A2365
D201A ON 466 pMD969 A2366
D275A ON 467 pMD970 A2367
D3N ON 682 pMD1175 A2798
D14N ON 683 pMD1176 A2799
D39N ON 684 pMD1177 A2800
E40Q ON 685 pMD1178 A2801
D124N ON 686 pMD1179 A2802
D195N ON 687 pMD1180 A2803
D201N ON 688 pMD1181 A2804
D275N ON 689 pMD1182 A2805
D3A/D275A – pMD1397 A3311
D14A/D275A – pMD1398 A3312
D39A/D275A – pMD1399 A3313
K100S ON 690 pMD1183 A2806
R122S ON 691 pMD1184 A2807
H126S ON 692 pMD1185 A2808
K187S ON 693 pMD1186 A2809
K202S ON 694 pMD1187 A2810
K269S ON 695 pMD1188 A2811
K100A ON 841 pMD1294 A3081
R122A ON 842 pMD1295 A3082
H126A ON 843 pMD1296 A3083
K187A ON 844 pMD1297 A3084
K202A ON 845 pMD1298 A3085
K269A ON 846 pMD1299 A3086
(STE2+ Host strain A230)
STE2+ – pMD240 A338
ste2-Δ – pMD228 A433
D3A ON 460 pMD963 A3303
D14A ON 461 pMD964 A3304
D39A ON 462 pMD965 A3305
E40A ON 463 pMD966 A3306
D124A ON 464 pMD967 A3307
D195A ON 465 pMD968 A3308
D201A ON 466 pMD969 A3309
D275A ON 467 pMD970 A3310
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ligands. One of the best-understood examples of GPCR ligand-
binding, the interaction of biogenic amines with their cognate
receptors, entails critical interactions between a conserved
aspartic acid residue in predicted TM3 of the receptor and
positive charges on ligand amines [11–13]. Similar counter-ion
pairs are involved in ligand binding to somatostatin, melanin
concentrating hormone, angiotensin, and lutropin/choriogona-
dotropin receptors [14–17].
The α-factor receptor encoded by the STE2 gene of baker's
yeast, Saccharomyces cerevisiae, is activated by binding to a
13-residue peptide pheromone (WHWLQLKPGQPMY),
resulting in induction of a pheromone response pathway that
prepares haploid cells for mating. α-factor receptors exhibit no
significant sequence similarity to mammalian GPCRs. How-
ever, the heterotrimeric G protein involved in the mating
pathway is very similar to mammalian G proteins and multiple
demonstrations of the functional interchangeability of mamma-
lian and yeast receptors confirm that the α-factor receptor and
mammalian receptors share a common signaling mechanism
[18,19].
The interactions between α-factor and its receptor that are
responsible for binding and receptor activation are not well
characterized. The α-factor peptide contains three potential
positively charged groups, the terminal amino group, His2, and
Lys7, but only one potential negatively charged group, the
terminal carboxyl group. The receptor contains eight potentially
negatively charged groups on its predicted extracellular surface
and one negative group in the predicted transmembrane region.
Several previous studies have implicated the positive charges on
α-factor in receptor binding and activation: (1) Removal of one
of the positive charges on α-factor by introduction of glutamic
acid or acetylated derivatives into the N-terminus of the peptide
resulted in a reduction of 20- to 100-fold in binding affinity for
receptor [20]. (2) Increasing the pH of binding reactions from
6.0 to 8.0 decreased receptor affinity approximately ten-fold
[21], suggesting that titratable positive charges on the amino
terminal or His2 might be involved in binding. (3) Replacement
of Lys7 with alanine in the tridecapeptide α-factor or acetylation
of this residue in the dodecapeptide analog led to a twenty-fold
lower affinity in the resulting ligands [22,23]. However, specific
electrostatic interactions between α-factor and Ste2p remain to
be identified, and the functional effects of electrostatic
interactions may be complicated by redundancy; when Lys7
of α-factor is modified with fluorescent groups or by
biotinylation, the resulting analogs exhibit nearly wild type
affinities for receptor [24,25]. Also, some α-factor analogs
containing substitutions at His2 are capable of high binding
affinity and efficient signaling [26].
Replacement of alanine for the only negative charge in the
transmembrane domains of the α-factor receptor, Glu143,
yields a fully functional receptor with a normal EC50 (ligand
concentration for half-maximal response) [27]. Thus, any
negatively charged groups important in ligand binding would
be expected to be located at the extracellular surface of Ste2p.
To examine the role of electrostatic interactions between α-
factor and its receptor, we assayed the signaling and bindingproperties of mutant receptors containing substitutions at the
sites of predicted extracellular negatively and positively
charged groups. This led to the identification of one residue
that appears to interact specifically with ligand, and to the
uncovering of a role for the polar nature of extracellular
negatively charged groups in receptor activation.
2. Materials and methods
2.1. Plasmids
Site-directed mutagenesis was used to make the desired mutations in the
triple HA-tagged allele of the STE2 gene encoded on the multicopy URA3
plasmid pMD240 [28]. The oligonucleotides used and the resulting plasmids
expressing the respective mutant receptor are listed in Table 1. Plasmids
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constructed by inserting a NheI–SacI-cut fragment from pMD970 into NheI–
SacI-cut pMD963, pMD964, and pMD965 respectively. All plasmids
containing single alanine substitutions were sequenced over the entire STE2
coding region to ensure that the observed phenotypes were due to the site-
directed changes.
2.2. Yeast strains and media
The yeast strains used in this paper are summarized in Table 1. The original
ste2-Δ host strain used was A232 (MATa ste2-Δ bar1-cry1R ade2-1 his4-580
lys2oc tyr1oc SUP4-3
ts leu2 ura3 FUS1::p[FUS1-lacZ TRP1]) [28]. Yeast
transformations were performed by the method of Chen et al. [29]. Yeast were
cultured on dropout media or YPD as described [30]. To test the dominant-
negative effects of alanine mutants the respective plasmids were transformed
into strain A230 carrying a chromosomal copy of the STE2+ gene [28]. The
resulting strains are listed in Table 1. pMD1397–pMD1399 were transformed
into A232 to obtain strains A3311–A3313, expressing double alanine mutant
receptors.
2.3. Assays of the yeast pheromone response
Liquid assays of FUS1-lacZ were performed as described by Martin et al.
[31] with some modifications. Yeast cultures expressing the mutant receptors
were grown to stationary phase and then diluted and cultured overnight to an
OD600 of approximately 0.4–0.6 in minimal media. 150 μl of cell culture was
then dispensed into a 96-well plate containing 10 μl samples of various α-
factor dilutions. When α-factor was used as a ligand, the peptide was initially
dissolved in water and diluted in 5 μg/ml solution of cytochrome c. When
fluorescent ligands were used, the peptides were initially dissolved and
diluted to 10 μl in 50% methanol. The cells were incubated with the
pheromone for 105 min at 30 °C and the OD600 was measured using an
absorbance plate reader (SpectraMax Gemini, Molecular Devices Corp.).
32 μl of a freshly made stock solution of the β-galactosidase substrate
fluorescein di-(β-D-galactopyranoside) (FDG) stock solution were then added,
so that the samples contained 0.8% Triton X-100, 23 mM PIPES (pH 7.2)
and 83 nM FDG. The reactions were allowed to proceed for 30 min at 37 °C
and then stopped by the addition of 32 μl of 1 M Na2CO3. Activity was
determined by measuring the emission at 530 nm with excitation at 485 nm
using a fluorescence plate reader (SpectraMax Plus, Molecular Devices
Corp.). For each plate, control wells were loaded with various concentrations
of purified β-galactosidase. The fluorescent activity of purified β-galactosi-
dase was plotted against the respective concentrations to obtain a standard
graph. The signaling capacity of each strain was defined as equivalent ng of
purified β-galactosidase activity divided by the OD600 value of the cells in
each well to normalize for the number of cells assayed. Assays were
conducted in triplicate using three independent yeast transformants of each
strain. The EC50 values were calculated by non-linear least-squares fitting of
the fluorescence values to the logarithm of the ligand concentrations using the
sigmoidal dose response equation from the ligand binding module of
Sigmaplot (SPSS Inc). Because of day-to-day variability in determinations of
EC50, this parameter is reported as a ratio of the EC50 value determined for a
strain expressing a mutant receptor to the EC50 value for a strain expressing
normal receptors, tested in a parallel assay with the same batch of ligand.
Halo assays of growth arrest were performed as described previously [28,32]
with the following modifications. Briefly, yeast cultures expressing the mutant
receptors were grown to stationary phase. These cultures were diluted and
grown overnight to an OD600 of approximately 1.0. A volume of yeast culture
corresponding to 3×106 cells was taken and the total volume was made up to
1.5 ml by water. The cell suspension was added to 2 ml of selective media
containing 1% bacto-agar and vortexed briefly. This mixture was then poured on
top of agar plates pre-warmed to 37 °C. This top agar was allowed to solidify
and then the indicated amounts of α-factor in a final volume of 3 μl were spotted
on each plate. All α-factor dilutions were made in water. The plates were
incubated for 48 h at 30 °C. The sizes of the halos were plotted against the doses
of α-factor spotted on the plates and the amount of α-factor required to produce
a 15-mm halo was calculated from a linear regression analysis of the semi-
logarithmic plot.2.4. Immunoblotting
Immunoblotting was performed as described in [28] with some modifica-
tions. The yeast extracts were loaded on a 12% SDS-polyacrylamide gel (with
4% stacking gel). Mouse anti-HA antibodies (1:3000 dilution) along with
horseradish peroxidase-conjugated goat anti-mouse antibodies (1:5000 dilution)
were used for immunodetection.
2.5. Binding assays
[K7(NBD), Nle12] α-factor, [Orn7(NBD), Nle12] α-factor and [Orn7(NBD),
E10, Nle12] α-factor were synthesized as described previously [24]. Stock
solutions were prepared and stored, and binding assays were conducted as
described by Bajaj et al. [33]. Briefly, yeast cultures to be used for binding
assays were grown to stationary phase, then diluted and cultured overnight.
When they reached an OD600 of 0.75–1.2, a volume of yeast culture
corresponding to 1.5×106 cells was transferred to polystyrene tubes on ice.
Ice-cold 20 mM MES pH 5.8 was added to bring the final volume to 500 μl.
These samples were incubated with the ligand solutions for 40–80 min on ice,
then vortexed briefly before analysis on a Becton and Dickinson FACSCalibur
flow cytometer using excitation at 488 nm. Samples were maintained on ice and
protected from light during pre-incubations and flow cytometry analysis.
Mean fluorescence values for a particular batch of yeast cells incubated at
ligand concentrations of 1, 3, 12, 50, 250, and 600 nM were corrected for
autofluorescence by subtracting the mean fluorescence value obtained for the
same culture in the absence of any ligand [33]. Binding data were analyzed using
the ligand binding module of Sigmaplot (SPSS Inc). Bmax and Kd values were
obtained by fitting to a binding equation that allowed for single-site specific
binding as well as a non-specific component:
Y ¼ ððBmax  LÞ=ðKd þ LÞÞ þ ðN  LÞ ð1Þ
where Y is the mean fluorescence of cells, N is the proportionality constant for
non-specific binding to cells and L is the ligand concentration in nM. The Bmax
and Kd values obtained were an average of at least three independent
experiments using independent yeast transformants. Except as noted, binding
assays were conducted using [Orn7(NBD), Nle12] as a ligand in order to allow
direct comparison with the available closely related [Orn7(NBD), Glu10, Nle12]
α-factor which differs only in the introduction of a negatively charged side chain
at position 10. Dissociation constants for fluorescent ligand binding to wild type
and mutant receptors at different pHs are presented in Tables 4 and 5 as ratios of
the Kds for mutant, compared with normal receptors assayed in parallel using the
same stock ligand solution. This was done because of variations in day-to-day
determinations of Kd, perhaps resulting from variations in stock solutions of
fluorescent ligands. Relative Bmax values represent the relative number of
binding sites per cell for binding of fluorescent ligand as described in legends to
the tables.
Ratios of fluorescence emission in two channels FL1 (515–545 nm) and FL2
(565–605 nm) of the FACSCalibur were calculated as follows: to evaluate
changes in emissions spectrum of receptor-bound ligand, the mean fluorescence
values obtained at different ligand concentrations in each channel were
individually fit to a saturation binding equation to obtain relative values of
Bmax as described above. The Bmax value in the green channel (FL1) was then
divided by the Bmax value in the red channel (FL2) to obtain a fluorescence ratio.
Binding of pheromone as a function of pH was conducted using the ligand
[K7(NBD), Nle12] α-factor, which provides an increased fluorescent signal
strength compared with the ornithine-containing pheromone analogs. The ligand
was tested at concentrations of 0, 3, 12, 50, 600 and 1000 nM. Binding was
conducted in 20 mM sodium acetate at pH 4.5, in 20 mMMES at pH 5.8, and in
20 mM PIPES at pH 7.2.
3. Results
As a test of the role of electrostatic interactions in activation
of the α-factor receptor by ligand, we constructed a set of
mutant receptor alleles in which each of the aspartic and
glutamic acid residues predicted to reside at the extracellular
Fig. 2. Percentage of FUS1-lacZ induction in response to 0 nM, 10 nM, and
2 μM α-factor for eight mutant receptor alleles containing alanine substituted for
acidic residues. The results are shown as mean±SEM of at least three
independent experiments. The strains expressing the D3A, D14A, D39A, E40A,
D124A, D195A, D201A, and D275A mutants are A2360, A2361, A2362,
A2363, A2364, A2365, A2366, and A2367 respectively. The strain expressing
normal Ste2p is A448. All receptors contain an HA epitope attached at the
carboxyl terminal and all are expressed from multicopy plasmids.
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an isosteric uncharged polar residue (glutamine for the glutamic
acid residue; asparagine for the aspartic acid residues) (Fig. 1).
The mutant receptor alleles were expressed from multicopy
plasmids in yeast strains that contain a deletion of the normal
chromosomal STE2 gene.
3.1. Effects of substitutions at D275
We initially examined the ability of the substituted receptor
alleles to induce expression of a lacZ reporter gene fused to the
promoter of FUS1, a gene that is transcriptionally induced in
response to activation of the pheromone response pathway.
Defects in induction of FUS1-lacZ expression were detected for
all of the receptor alleles containing alanine substituted for
negatively charged residues, ranging from about 20–50% of the
response of normal receptors at the saturating concentration of
2 μM α-factor. However, substitution of alanine for aspartic
acid at position 275 had a stronger detrimental effect on receptor
function than any of the other substitutions. This was
particularly evident at the sub-saturating concentration of
10 nM α-factor where the D275A allele exhibited approxi-
mately 5% of the normal response (Figs. 2 and 3). Fitting of
dose–response curves yielded an EC50 value for this allele that
is approximately five times higher than that for normal receptors
(p<0.05; Table 2).Fig. 1. Location of Ste2p extracellular negative (large filleCells expressing receptors containing the D275A substitu-
tion also exhibited a substantial defect in pheromone-induced
growth arrest (Table 3). In long-term assays of growth inhibitiond circles) and positive charges (large unfilled circles).
Fig. 3. Signaling of double alanine mutants in liquid assays of FUS1-lacZ induction. Strains shown in each panel of the figure were assayed simultaneously. The results
are an average of at least three independent experiments. The error bars represent standard error. The strains expressing the wild type receptor and single alanine
mutants were the same as used in Fig. 2. The strains expressing double alanine mutants D3A/D275A, D14A/D275A, and D39A/D275A are A3311, A3312, and A3313
respectively.
Table 3
Relative activity in a growth arrest assay of STE2 alleles containing substitutions
at extracellular charged groups
Yeast strain STE2 allele Relative activity a
A448 STE2+ 100
A2360 D3A 56±10
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various amounts of pheromone applied to culture plates, cells
expressing the D275A allele exhibited small, indistinct, halos,
for which it was not possible to measure reliable diameters
(Table 3).
It is unlikely that the defects in signaling by D275A mutant
receptors result from changes in expression level because the
pheromone response is remarkably independent of changes in
expression levels of pheromone receptors [28,34]. Furthermore,
normal and mutant alleles were expressed from multicopy
plasmids to minimize any possible effects of reduced expressionTable 2
Fold change in EC50 values for STE2 alleles containing single or double
substitutions at extracellular negatively charged groups in a reporter gene assay
Yeast strain STE2 allele EC50 fold change
a
A448 STE2+ 1
A2360 D3A 1.9±0.5 b
A2361 D14A 1.7±0.3 b
A2362 D39A 1.9±0.3 b
A2363 E40A 2.0±0.5 b
A2364 D124A 2.3±0.8
A2365 D195A 1.2±0.5
A2366 D201A 1.1±0.4
A2367 D275A 4.9±0.6 b
A3311 D3A/D275A 2.2±0.3 b
A3312 D14A/D275A 3.6±0.7 b
A3313 D39A/D275A 3.1±0.5 b
A2798 D3N 0.6±0.1
A2799 D14N 1.0±0.2
A2800 D39N 0.8±0.3
A2801 E40Q 1.0±0.3
A2802 D124N 0.9±0.2
A2803 D195N 1.5±0.5
A2804 D201N 1.0±0.3
A2805 D275N 0.7±0.1 b
a The fold change in EC50 was calculated as EC50 of mutant alleles/EC50 of
wild type Ste2p. The values are expressed as the mean±SEM of at least three
independent experiments.
b The change in EC50 for these alleles (compared with STE2
+) was
statistically significant at the level of p<0.05.of mutant alleles. Immunoblotting of whole-cell extracts using
an antibody to the HA epitope fused to the C-terminal of normal
and mutant receptors indicated that the D275A mutant receptor
was present at normal levels in cells (Fig. 4). (The lowerA2361 D14A 49±6 b
A2362 D39A 51±7 b
A2363 E40A 55±7 b
A2364 D124A 50±6 b
A2365 D195A 48±6 b
A2366 D201A 46±5 b
A2367 D275A N.D. c
A2798 D3N 79±12
A2799 D14N 70±10
A2800 D39N 77±11
A2801 E40Q 76±11
A2802 D124N 87±13
A2803 D195N 82±11
A2804 D201N 73±13
A2805 D275N N.D. d
A3081 K100A 89±15
A3082 R122A 106±18
A3083 H126A 144±8 b
A3084 K187A 136±24
A3085 K202A 95±16
A3086 K269A 101±26
a Relative activity is calculated as: (α-factor required to produce a 15 mm halo
in the wild type Ste2p/α-factor required to produce a 15 mm halo in the mutant
alleles)×100. The values are expressed as mean±SEM of at least three
independent experiments.
b The change in activity for these alleles (compared with STE2+) was
statistically significant at the level of p<0.05.
c N.D., Not Determined; Halos for this strain had indistinct edges and had
smaller diameters than halos for strains expressing wild-type receptors.
d N.D., Not Determined; Halos for this strain had indistinct edges but were
approximately the same size as the halos of strains expressing wild-type
receptors.
Fig. 4. Immunoblot analysis of levels of Ste2p in whole-cell lysates for wild type
and mutant alleles. The blots were developed using anti-HA antibodies. The
molecular weights are shown on the right. The strains expressing the wild type
receptor and the alanine mutants are same as used in Fig. 2.
Fig. 5. Percentage FUS1-lacZ induction of receptors containing asparagine and
glutamine substituted for aspartic and glutamic acid residues in response to
2 μM α-factor. The results are shown as mean±SEM of at least three
independent experiments. The strains expressing the empty vector and the wild
type receptor are same as used in Fig. 2. The strains expressing D3N, D14N,
D39N, E40Q, D124N, D195N, D201N, and D275N mutant receptors are
A2798, A2799, A2800, A2801, A2802, A2803, A2804, and A2805
respectively.
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degradation products resulting from proteolytic removal of N-
terminal sequences from mutant and wild-type receptors.)
However, the number of cell-surface binding sites for
pheromone was drastically reduced in cells expressing the
D275A allele, based on a flow cytometry-based assay for
binding of fluorescently-labeled ligand [Orn7(NBD), Nle12] α-
factor [24,33] (Table 4).
Substitution of asparagine for aspartic acid at position 275
resulted in more moderate defects in receptor function than were
seen for alanine at this position. Receptors containing the
D275N substitution responded normally to α-factor in assays of
FUS1-lacZ induction with little change in EC50 (Fig. 5 andTable 4
[Orn7(NBD), Nle12] α-factor binding to STE2 alleles containing substitutions at
extracellular negatively charged groups
Yeast strain STE2 allele Relative Bmax
a Relative Kd
a FL1/FL2 b
A448 STE2+ 1 1 0.68±0.006
A2360 D3A 1.2±0.1 1.7±0.4 0.68±0.007
A2361 D14A 0.7±0.1 0.5±0.1 0.70±0.008
A2362 D39A 1.0±0.1 0.7±0.2 0.68±0.003
A2363 E40A 1.0±0.1 0.8±0.2 0.66±0.007
A2364 D124A 0.8±0.1 0.9±0.2 0.69±0.003
A2365 D195A 0.8±0.1 1.3±0.3 0.69±0.009
A2366 D201A 0.8±0.1 1.0±0.3 0.71±0.015
A2367 D275A NDc NDc NDc
A2805 D275N 0.5±0.1 3.4±1.0 0.86±0.029
a Relative Bmax values are calculated as the ratio of the number of binding
sites on the mutant strain to the number of binding sites on the STE2+ strain,
assayed in parallel. Relative Kd values are calculated as the ratio of the Kd for the
mutant allele to the Kd for the STE2
+ strain. Bmax and Kd values for each strain
were derived from fitting of fluorescence emission as described in Materials and
methods. Relative Bmax and Kd values are expressed as mean±SEM of at least
three independent experiments.
b Ratio of relative fluorescence emissions in the FL1 (515–545 nm) and FL2
(565–605 nm) channels of the flow cytometer, presented as mean±SEM of at
least three independent experiments.
c The number of cell surface binding sites for this mutant was too low to
permit reliable fitting to the binding equation.Table 2). However, in the longer term assays of growth arrest,
cells expressing receptors with asparagine at this position
exhibited only partial growth arrest in response to α-factor,
resulting in halos with turbid edges that prevented reliable
determination of halo diameters (Table 3). In contrast to the case
for D275A, cells expressing the D275N allele exhibited
detectable binding of [Orn7(NBD), Nle12] α-factor at the cell
surface, however, both numbers of binding sites and the affinity
for ligand of the D275N mutant are lower than for normal
receptors (Table 4). The fluorescence emission of the [Orn7
(NBD), Nle12] α-factor bound to the D275N receptor is also
blue-shifted, compared with the same analog bound to normal
receptors, as indicated by a higher ratio of fluorescence
emission in the FL1 channel (515–545 nm) relative to FL2
channel (565–605 nm) (Table 4). This small, but significant
shift (p<0.05) suggests that the NBD fluorophore resides in a
more hydrophobic site on the D275N mutant than the compara-
ble site on normal receptors (see [24,33]).
If the aspartic acid residue at position 275 is involved in
electrostatic interactions with ligand, substitutions at this
residue might be expected to alter the pH dependence of ligand
binding. Thus, we compared the binding of [Orn7(NBD), Nle12]
α-factor to cells expressing normal or D275N receptors at pH
4.5, 5.8, and 7.2. Consistent with previous reports [21], as pH
increases, we detect a decrease in affinity of binding of this
ligand to normal receptors (data not shown). While we were
able to detect specific binding of this ligand to D275N receptors
at all three pHs, the pH-dependence of binding to the mutant
receptor was not significantly different from that for normal
receptors. This could either be because no such difference
exists, or because of the difficulty of fitting accurate dissocia-
tion constants to binding data for this relatively weakly-
fluorescing ligand [24] to mutant receptors that are present at
reduced abundance.
Fig. 6. pH-dependence of binding of [K7(NBD), Nle12] α-factor to normal and D275N mutant receptors. Data points represent the mean±SEM for three independent
isolates of each strain. Binding of [K7(NBD), Nle12] α-factor to strains A448 (STE2+) and A2805 (D275N) was assayed at pH 4.5 (panel A), pH 5.8 (panel B), and pH
7.2 (panel C). Solid lines indicate the results of least squares fitting to the data for strain A448 as described in Materials and methods. Dashed lines represent the fit to
data for strain A2805. The data for strain A448 at all pHs and for strain A2805 at pH 4.5 were fit as single site binding with a nonspecific component as described in
Materials and methods. The data for strain A2805 at pH 5.8 and pH 7.2 were fit to a linear regression passing through the origin.
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and mutant receptors using an alternative ligand, [K7(NBD),
Nle12] α-factor, that provides an enhanced signal to noise ratio
compared to [Orn7(NBD), Nle12] [24]. Binding of [K7(NBD),
Nle12] α-factor to D275N mutant receptors exhibits a stronger
pH-dependence than binding to normal receptors. Binding to
mutant receptors was readily detected at pH 4.5, albeit with more
than 10-fold lower affinity and a four-fold lower Bmax than its
binding to normal receptors at this pH (Fig. 6 and Table 5).
However, at pH 5.8 or pH 7.2, no specific binding of [K7(NBD),
Nle12] α-factor to cells expressing D275N mutant receptors
could be detected (Fig. 6). In contrast, binding of [K7(NBD),
Nle12] α-factor to normal receptors was readily detected at pHs
4.5, 5.8, and 7.2, exhibiting an approximately 10-fold decrease
in affinity as pH increased from 4.5 to 5.8, but little additional
change as the pH increased further to 7.2 (Table 5). The changes
that we observe in binding as a function of pH apparently reflect
alterations in ligand affinity, rather than the changes in theTable 5
[K7(NBD), Nle12] α-factor binding to normal and D275N receptors
Allele, pH a Relative Bmax
b Relative Kd
b FL1/FL2 c
STE2+ pH 4.5 1 1 1.31±0.05
STE2+ pH 5.8 1.1±0.1 11.8±1.6 1.11±0.08
STE2+ pH 7.2 0.9±0.1 10.0±1.6 1.39±0.09
D275N pH 4.5 0.3±0.1 17.4±9.7 0.47±0.02
D275N pH 5.8 NDd NDd NDd
D275N pH 7.2 NDd NDd NDd
a Binding was assayed in strains A448 (STE2+) and A2805 (D275N).
b Relative Bmax values are calculated as the ratio of the number of binding
sites on the relevant strain at the indicated pH to the number of binding sites on
the STE2+ strain at pH 4.5, assayed in parallel. Relative Kd values are calculated
as the ratio of the Kd for the relevant strain at the indicated pH to the Kd for the
STE2+ strain at pH 4.5. Bmax and Kd values for each strain were derived from
fitting of fluorescence emission as described in Materials and methods. Relative
Bmax and Kd values are expressed as mean±SEM of at least three independent
experiments.
c Ratio of relative fluorescence emissions in the FL1 (515–545 nm) and FL2
(565–605 nm) channels of the flow cytometer.
d The extent of binding under these conditions was too low to allow reliable
determination of binding parameters.
Fig. 7. Ligand-specific defects in FUS1-lacZ induction by cells expressing
D275N mutant receptors. Activation of FUS1-lacZ expression in response to
fluorescent ligands was assayed as described in Materials and methods. The
strains used were A448, expressing normal receptors, A2805, expressing
D275N mutant receptors, and strain A454, expressing no α-factor receptors.
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to the incubations with ligand, and since fitting of the binding of
[Orn7(NBD), Nle12] α-factor, which binds to the same sites, but
exhibits a weaker pH-dependence of binding affinity, yielded a
constant Bmax value over measurements at different pHs.
Despite the nearly normal response of D275N mutant
receptors to normal α-factor in assays of FUS1-lacZ induction
(Table 2), these mutant receptors are much less sensitive than
normal receptors to the alternate ligand [K7(NBD), Nle12] α-
factor. The EC50 for activation of D275N by [K
7(NBD), Nle12]
α-factor is approximately ten-fold higher than the EC50 for
activation of wild-type receptors by this ligand (Fig. 7). Thus,
for [K7(NBD), Nle12] α-factor concentrations in the range of
12–50 nM, significantly lower levels of FUS1-lacZ expression
are induced by mutant receptors than by normal receptors
(p<0.01) (Fig. 7). In contrast, no significant differences are
detected in the responses of normal and D275N mutant
receptors to the ligand [Orn7(NBD), Nle12] α-factor (p<0.2).
Taking advantage of the previously-reported strong shift in
emission wavelength of [K7(NBD), Nle12] α-factor on
binding to normal receptors [24,33], we examined emission
spectra of this ligand bound to normal and D275N receptors.
There is a nearly 3-fold decrease (p<10−4) in the FL1/FL2
channel ratio for the emission of [K7(NBD), Nle12] α-factor
bound to the mutant receptor, compared to the same ligand
bound to normal receptors (Table 5). This strong red-shift
indicates that the NBD fluorophore binds in a more polar
environment on the mutant, compared with the normal
receptor. No significant changes in channel ratio were detected
for binding of [K7(NBD), Nle12] α-factor to normal receptors
at different pHs (Table 5).
3.2. Effects of substitutions at other charged residues
If particular negatively charged residues on the receptor are
involved in direct interactions with oppositely charged groups
on the ligand, substitution of uncharged residues at these
positions on the receptor would be expected to lead to loss of
ligand affinity or signaling function, whereas substitution of
alanine for negatively charged groups that are not involved in
such interactions would have minimal effects. While the
phenotypes we have detected for substitutions at position 275
in Ste2p are more drastic than those resulting from similar
substitutions at other acidic residues, we were surprised to find
that substitution of alanine for any of the seven additional
negatively charged groups on the extracellular surface of the
receptor resulted in an approximately 2-fold reduction in
maximal FUS1-lacZ induction in response to a saturating
concentration of pheromone (Figs. 2 and 3). This reduction in
maximal response was accompanied by only modest (2-fold or
less) increases in EC50 (Table 2). All the alanine-substituted
mutants also exhibited signaling defects in a long-term growth
arrest assay compared to normal receptor (Table 3). Aside from
the D275N allele (see above), no significant defect in function
was detected for receptors containing isosteric polar amino
acids substituted for negatively charged residues (Fig. 5 and
Tables 2 and 3).Immunoblotting of whole-cell extracts from cells expressing
the seven alanine-substituted receptors (Fig. 4) confirmed that
six of them were present at normal levels. Expression of the
D124A mutant was slightly lower than normal. However, this is
unlikely to be the cause of the observed signaling defect of the
D124A allele, since it is one of the least defective among the
tested alleles, and since its level of expression is significantly
higher than that of wild-type chromosomally-encoded Ste2p that
provides normal signaling responses. Cells expressing the
remaining seven alanine-substituted alleles display normal
numbers of receptors on the cell surface that bind [Orn7(NBD),
Nle12] α-factor with normal affinity (see [24,33], Table 4). Thus,
for these seven alleles, the observed defect in signaling is not due
to improper folding of the receptor, poor cell surface expression
levels, or reduced binding affinity. Furthermore, there was no
significant difference between the fluorescence emission spectra
of the environmentally-sensitive NBD fluorophore of [Orn7
(NBD), Nle12] α-factor bound to these mutant receptors,
compared with wild-type receptors (see [24,33], Table 4).
We also assayed binding to normal and mutant receptors
by an additional α-factor analog, [Orn7(NBD),E10,Nle12]
α-factor, that differs from [Orn7(NBD), Nle12] α-factor only
in the substitution of a negatively charged glutamic acid for
the normal glutamine residue at position 10. This was done to
examine the possibility that loss of negatively charged groups
on mutated receptors might allow enhanced binding of ligand
containing an extra negative charge, compared with binding of
Glu10-containing ligand to normal receptors. However, for
each of the charge-substituted receptors for which binding
could be measured, the binding affinity of the Glu10 analog
was the same as or lower than that for binding to normal
receptors (results not shown).
The signaling defects produced by the D275A substitution
were not generally additive when combined with other alanine
substitutions (Fig. 3). In fact, a modest suppression of the defect
in pheromone-responsive FUS1-lacZ induction was seen when
D275A was combined with certain other substitutions (Fig. 3).
None of the alanine-substituted mutations that we created
exhibited significant dominant negative behavior (results not
shown). This was tested by examining FUS1-lacZ induction in
response to α-factor in cells containing multicopy plasmids
encoding the mutant receptors as well as a normal chromosomal
copy of the STE2 gene.
To determine whether the effects of charge substitutions in
the receptor were specific to substitutions of negatively charged
residues, we substituted serine and alanine, one at a time, for
each of the six positive charges that are predicted to reside at the
extracellular surface of the receptor: Lys100, Arg122, His126,
Lys187, Lys202, and Lys269. Receptors containing each of
these substitutions responded to α-factor with approximately
the same or even better sensitivity compared with the normal
allele in the growth arrest assay. Results of the alanine
substitutions are presented in Table 3. This is consistent with
previous reports in which individual replacements of positive
charges at position 100, 122, 126, 202 and 269 with cysteine
residues and replacement of the Lys269 with alanine results in
receptors with normal pheromone responses [35–37].
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Electrostatic interactions play important roles in signaling
and ligand binding of many mammalian GPCRs [11,14,15]. To
examine the role of these interactions in ligand binding and
recognition by the yeast α-factor receptor, we generated a series
of mutant receptors containing individual substitutions of either
alanine or an uncharged polar residue in place of one of the
eight negative charges and six positive charges predicted to
reside at the receptor's extracellular surface. Substitutions at
one negatively charged amino acid, Asp275, resulted in more
severe defects than similar changes at other extracellular
charged amino acids in the receptor. Cells expressing α-factor
receptors containing alanine in place of Asp275 exhibited
severely diminished pheromone-dependent induction of a
FUS1-lacZ reporter gene and only weak growth arrest in the
presence of pheromone. Furthermore, no detectable binding of
ligand to the D275A mutant receptors could be detected at the
cell surface, even though these mutant receptors are present at
normal levels in whole-cell extracts. The more conservative
substitution D275N also resulted in a defect in response to α-
factor in the growth arrest assay, reduced abundance of cell-
surface binding sites, decreased affinity for ligand, changes in
the fluorescence emission spectra of bound fluorescent ligands,
and a ligand-specific reduction in induction of FUS1-lacZ
expression in response to the fluorescent agonist [K7(NBD),
Nle12] α-factor.
Since receptors containing substitutions of either Asn or Ala
for Asp275 retain significant abilities to induce FUS1-lacZ
expression in response to pheromone, there must be at least a
small population of each of these mutant receptors that reaches
the cell surface and is capable of binding ligand. In the case of
D275A, this population is too small to be detected in assays of
fluorescent α-factor binding. In the case of D275N, cell surface
binding can be detected, though both the affinity and number of
sites are less than what is observed for normal receptors. Thus,
mutations at D275 appear to affect both trafficking to the cell
surface and binding of ligand by receptors that reach the
surface. A lack of correlation between ligand binding affinities
and dose–response relations of mutated α-factor receptors has
been documented previously [38,39].
The more severe defects observed for the D275A and D275N
mutants in the long term growth arrest assay, compared with the
short-term FUS1-lacZ reporter assay, are consistent with the
previously-described insensitivity of the reporter gene assay to
changes in levels of receptor expression [28,40]. Other
previously-isolated ste2 mutations exhibit stronger phenotypes
in the growth arrest assay than in the induction assay [40,41].
The fact that the D275N mutation in Ste2p induces shifts in
the emission spectra of receptor-bound fluorescent ligands,
while maintaining a native-like fold as indicated by high ligand-
binding affinities, provides strong evidence for physical
proximity between Asp275 and the fluorophore of the bound
ligand. If the interactions between Ste2p and ligand include an
electrostatic component that involves Asp275, mutational
removal of the ionizable group at this position would be
expected to lead to alteration of the pH-dependence of ligandbinding. In fact, the complete loss of detectable binding of
[K7(NBD), Nle12] α-factor to D275N receptors at pHs above
4.5, compared with the more modest decrease in affinity of
normal receptors for this ligand at the higher pHs, provides
evidence for such an electrostatic interaction. Thus, the negative
charge of the ionized aspartic acid at high pHs appears to
provide a favorable interaction with ligand, whereas replace-
ment of this residue by neutral asparagine results in lower
affinity. However, the overall enhanced affinity of normal
receptors for ligand that is observed at low pH must be due to
electrostatic effects of groups other than Asp275, since ionic
interactions involving Asp275 would be expected to be weakest
under acid conditions where the aspartic acid is protonated.
Some of the pH dependence of binding of fluorescent ligands
could be due to protonation of the derivatized Lys7, which, as an
aniline derivative, is expected to be a weaker base than the
unmodified lysine. However, an overall decrease in ligand
affinity with increasing pH is seen with unmodified α-factor as
well as the fluorescent analogs [21].
Subtle differences between the ligands used in this study
resulted in remarkable differences in their interactions with
normal and mutant receptors: (1) Although normal and D275N
mutant receptors responded similarly to normal α-factor and to
[Orn7(NBD), Nle12] α-factor, there are significant differences
between the responses of normal and D275N mutant receptors
to a third ligand, [K7(NBD), Nle12] α-factor. (2) The
fluorescence emission of [Orn7(NBD), Nle12] α-factor bound
to D275N mutant receptors is slightly blue-shifted compared
with the same ligand bound to normal receptors, whereas the
emission of [K7(NBD), Nle12] α-factor bound to mutant
receptors is strongly red-shifted compared with the binding of
this ligand to normal receptors. (3) We have detected difference
in the pH dependence of binding of different fluorescent ligands
to D275N mutant receptors.
One explanation of the differential effects of the D275N
mutation on the binding and activity of different ligands would
be that the NBD group on the side-chain of the lysine-
containing ligand extends into a hydrophobic pocket near
Asp275 of the normal receptor. Local structural changes
resulting from substitution of asparagine for aspartic acid at
this position could either render this hydrophobic pocket
inaccessible to the NBD group or open the pocket up to
solvent, reducing binding affinity and preventing the blue-shift
of the lysine-containing ligand. In contrast, the fluorophore
attached via the shorter side chain of [Orn7(NBD), Nle12] α-
factor may not be able to reach into the pocket of normal
receptors, explaining the lack of blue-shift upon binding to
normal receptors and the weaker effects of the D275N
substitution on binding affinity, potency, and fluorescence
emission of the ornithine-containing ligand. Different behaviors
of [Orn7(NBD), Nle12] α-factor and [K7(NBD), Nle12] α-factor
are not likely to be caused by differences between the extents of
ionization of the NBD-derivatized ornithine and lysine side
chains, since their pKs should not differ greatly.
Replacement of Asp275 by valine in Ste2p has previously
been reported to result in a defective, dominant-negative,
receptor [42], consistent with our observation that substitution
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function. However, we have not been able to detect dominant
effects of the D275A allele, perhaps because of reduced
expression of the D275A allele at the cell surface. On the other
hand, replacement of Asp275 by cysteine was reported to result
in a normal receptor, as assayed by growth arrest [37]. In
contrast, our finding that the more conservative replacement of
asparagine for Asp275 leads to filled-in halos, may reflect
different steric and electrostatic properties of the side chains of
asparagine and cysteine, different plasmid and host back-
grounds, or differences in details of assay protocols. Our
observation that receptors bearing the D201A substitution
exhibit a slight defect in signaling is also somewhat at variance
with an earlier report stating that a receptor bearing this same
substitution exhibits normal responses to α-factor in a growth
arrest assay [43]. However, this might also be a function of the
different plasmid copy numbers, receptor tags, and host strains,
or sensitivity of assay conditions used in these two studies.
Substitution of polar uncharged residues at the positions of
the thirteen positively and negatively charged extracellular
amino acids (other than Asp275) resulted in receptors that retain
nearly normal signaling function in short-term assays of FUS1-
lacZ reporter gene induction, as well as longer-term assays of
growth arrest. Since substitution of an uncharged residue for
Glu143, the only potentially negatively charged residues in the
predicted transmembrane segments of the receptor, did not
diminish signaling function [27], we conclude that no single
electrostatic interaction, either between the receptor and the
ligand or between oppositely charged groups in the receptor, is
strictly required for ligand binding or activation of this receptor.
Three possible explanations for this lack of electrostatic effects
are: (1) The ionizable groups on the ligand are uncharged upon
formation of the receptor–ligand complex. (This would be
particularly relevant for the histidine residue and the amino
terminal with pKas near neutral); (2) The charged moieties of the
ligand are exposed to solvent in orientations facing away from
the receptor; or (3) Electrostatic interactions that are important
for receptor activation are redundant, such that removal of any
particular interaction does not significantly affect receptor
function. Thus, a generalized charge distribution or overall
electrostatic potential at the extracellular surface, as opposed to
individual charged groups, may be involved in receptor
activation, as was shown for positively charged groups on the
third intracellular loop of Ste2p [44].
The partial loss of responsiveness to ligand that we observe
upon substitution of alanine at seven of the eight negatively
charged amino acids on the extracellular surface of Ste2p does
not result from reduced expression, inefficient targeting to the
plasma membrane, or inability to bind ligand, based on
immunoblotting and assays of cell surface binding of α-factor.
The lack of effect of these substitutions on ligand binding
affinity and on the fluorescence emission spectra of the bound
fluorescent ligand implies that the affected residues are not
likely to be involved in direct interactions with ligand. Thus,
these mutations must either impair the ability of the receptor to
become activated in response to ligand binding or promote
enhanced receptor desensitization, although the latter possibi-lity seems unlikely given the extracellular locations of the
changes. These seven alanine mutants are examples of rare
extracellular receptor mutations that affect intracellular
signaling without affecting binding [35].
We uncovered a dichotomy between the effects of alanine
substitutions at negatively charged, compared with positively
charged, residues. Introduction of alanine as a replacement for
any of the eight extracellular negatively charged residue
resulted in partial loss of function, whereas no similar
replacement of any extracellular positively charged residues
had any significant effect on signaling. Since it is unlikely that
all eight extracellular negative charges of the receptor are
directly involved in the receptor activation, the partial loss of
function observed on replacing them with alanine suggests that
they all contribute to the formation of one or more polar surfaces
that must be maintained for maximal receptor activation.
Although it might be expected that such polar surfaces would
contain co-mingled positively and negatively charged residues,
this does not appear to be the case, since introduction of alanine
in place of positively charged residues leaves receptor function
unchanged. The fact that combination of D275A with other
alanine substitutions at negatively charged residues is not
additive, and in some cases leads to partial reversal of the
signaling defect of D275A, suggests that the role of Asp275 in
interacting with ligand is not entirely distinct from the roles of
the other negatively charged extracellular residues in maintain-
ing active receptor function.
In rhodopsin, the only GPCR for which a complete
structure is available [8], negatively charged amino acid
residues are distributed relatively evenly throughout the three-
dimensional structure of extracellular regions of the receptor,
which contain few positively charged amino acids. While the
yeast α-factor receptor is functionally interchangeable with
many mammalian receptors, the very low level of sequence
similarity between Ste2p and rhodopsin and the unusual
covalent attachment of ligand to rhodopsin make it difficult to
draw inferences about α-factor binding based on comparison
to the rhodopsin structure.
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